Cargando…
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
Since the onset of antiviral therapy, viral resistance has compromised the clinical value of small-molecule drugs targeting pathogen components. As intracellular parasites, viruses complete their life cycle by hijacking a multitude of host-factors. Aiming at the latter rather than the pathogen direc...
Autores principales: | Prussia, Andrew, Thepchatri, Pahk, Snyder, James P., Plemper, Richard K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131607/ https://www.ncbi.nlm.nih.gov/pubmed/21747723 http://dx.doi.org/10.3390/ijms12064027 |
Ejemplares similares
-
Asymmetric synthesis of host-directed inhibitors of myxoviruses
por: Moore, Terry W, et al.
Publicado: (2013) -
Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses
por: Brinton, Margo A, et al.
Publicado: (2019) -
Next-generation direct-acting influenza therapeutics
por: Toots, Mart, et al.
Publicado: (2020) -
Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs
por: Xie, Dafei, et al.
Publicado: (2022) -
Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases
por: Krumm, Stefanie A., et al.
Publicado: (2011)